Introduction {#s1}
============

The number of persons aged 50 years and older living with HIV/AIDS has been increasing over the past two decades ([@R12]; [@R34]). More middle-aged and older adults are contracting new HIV infections, and more people living with HIV (PLWH) disease are living longer due to medical treatment advances ([@R27]; [@R33]; [@R34]; [@R49]). The cumulative number of AIDS cases among persons aged 50 and older quintupled between 1990 and 2001 ([@R34]) and rose again by 77% between 2001 and 2005, accounting for 25% of all HIV cases and 29% of all persons living with AIDS in the USA ([@R12]; [@R35]). The CDC estimates that by 2015 over half of the HIV-positive population in the US will be 50 years or older ([@R48]). This dramatic rise in the number of older PLWH may have important implications for medical outcomes, functional status, and quality of life (QoL). Older persons may not respond as well to treatment as younger persons due to being diagnosed later in the disease course if needs for HIV testing are more slowly recognized ([@R21]), having less reserve immune functioning, having more comorbid medical conditions, or experiencing more medication side effects ([@R13]; [@R27]; [@R47]).

The interaction of HIV with the aging process and common comorbities of aging are expected. In those with long-term HIV infection, the persistent activation of immune cells by the virus likely increases the susceptibility of these individuals to inflammation-induced diseases and diminishes their capacity to fight certain diseases ([@R3]). Coupled with the aging process, the extended exposure of these older adults to both HIV and antiretroviral drugs appears to increase their risk of illness and death from HIV associated non-AIDS conditions (HANA) such as cardiovascular, bone, kidney, liver, and lung disease, as well as many cancers not associated directly with HIV infection ([@R19]; [@R24]). In addition, a growing number of adults in their 40s and 50s with long-term HIV infection and treatment are experiencing syndromes that resemble premature aging. For instance, these individuals have a greater risk of impaired kidney function, end-stage renal disease, ([@R18]) osteoporosis ([@R9]), and show signs of accelerated frailty ([@R17]). In one large observational study of older PLWH in New York City, 91% of the sample reported at least one other chronic condition in addition to HIV, and 77% reported two or more comorbidities ([@R8]). In a large sample of US veterans ([@R22]) found lower rates of comorbid conditions among those HIV-positive above the age of 50 with about 53--66% reporting a comorbid condition. In addition, their sample showed an interaction between age and HIV, in that patients that are HIV-positive are more likely to have a comorbid illness as they get older compared to their HIV-negative counterparts. Another interesting finding was that the HIV-negative persons reported higher rates of comorbid conditions compared to those who were HIV-positive ([@R22]).

Since HIV has become a chronic disease with the prospect of long-term survival, examination of the burden of HIV, and comorbid conditions, on health-related quality of life (HRQOL) has become increasingly important ([@R45]). [@R50] reported that 13 aspects of QoL were poorer in older adults with HIV. [@R46] examined results from eight countries and found across 30 facets of QoL that those aged 40 + had higher QoL and reported eight areas in which they were doing relatively well including positive feelings, safety, home environment, and spirituality, but had poorer energy, sleep, and sex-life. In PLWH, lower HRQOL has been shown to be associated with older age and with lower CD4 counts ([@R11]). Moreover, physical function decreases more rapidly with age in PLWH compared to uninfected patients ([@R38]). While persons with asymptomatic HIV have physical functioning comparable to those without HIV, those with symptomatic HIV report significantly worse physical functioning and those with AIDS report worse physical functioning compared to persons with other types of chronic diseases such as diabetes, prostate cancer, or depression ([@R25]). Although increased age is associated with reduced physical functioning in both HIV-infected and HIV-negative patients, comorbid conditions appear to mediate this relationship even after controlling for the impact of antiretroviral therapy (ART) and HIV disease stage ([@R39]). These findings demonstrate the potentially important role of general medical comorbidity in the physical functioning of PLWH ([@R39]) and raise questions about the impact that multiple comorbidities may have on the overall HRQOL of an aging HIV population.

Health-related quality of life has shown to be related to depression and stress in PLWH ([@R37]; [@R45]). Independent of other chronic illnesses, depression predicts reduced physical functioning in PLWH ([@R39]). Depression is the most common comorbid condition for PLWH, with prevalence rates threefold higher than the general population ([@R28]). In a large sample of persons over 50 with HIV approximately 39% exhibited symptoms of major depression ([@R23]). In HIV populations, rates of depression do not appear to decline as they do in the general population ([@R42]) and thus depression becomes increasingly relevant in older HIV-positive populations. There is evidence that the number of HIV symptoms is an independent predictor of screening positive for psychological disorders ([@R7]). Furthermore, there is evidence that depression and stress are adversely associated with HIV disease progression including decreased CD4 T-lymphocytes, increases in viral load, and greater risk for clinical decline and mortality ([@R32]). Older adults who endorsed more psychological symptoms also report more HIV-related life-stressor burden, less support from friends, and reduced access to health care and social services due to AIDS-related stigma ([@R26]). Despite the known interaction between HIV, depression, and QoL, there remains a dearth of research examining the intersection of these concepts in older persons with HIV ([@R29]).

In sum, the population of PLWH is growing older and more prone to developing other chronic health conditions. HRQOL is related to disease symptomatology and progression. How chronic disease burden, as defined by the number of chronic medical conditions, relates to QoL challenges of older adults living with HIV is not well understood and has not been examined in a community sample in multiple geographic locations. This study describes the relationship of comorbid chronic health conditions to physical, social, and mental health functioning in a nine-state community sample of older adults living with HIV. Based on prior research it is hypothesized that PLWH 50 years and older will report frequent rates of chronic health problems. Furthermore, we hypothesized that self-reported HRQOL, depression, and stress would be strongly related to the reported number of chronic conditions.

Methods {#s2}
=======

Design {#s3}
------

Data from this cross-sectional, observational study was collected as part of a pre-treatment telephone survey for the PRIME project. The PRIME project is a randomized controlled trial of a telephone-delivered self-management intervention for HIV-positive persons aged 50 years and older. The Group Health IRB approved all procedures.

### Recruitment, eligibility, and sample {#s4}

Participants were recruited from AIDS Service Organizations (ASOs) in nine states (Wisconsin, Texas, Illinois, Pennsylvania, Michigan, Massachusetts, Arizona, California, and Washington) through posters, flyers, and direct mailings. Interested persons called the study toll-free number and completed a brief screener. Eligible participants were then called to complete a 30-minute baseline telephone survey. Participants were compensated \$30 for completing the survey. Eligible participants were 50 years or older, HIV-positive, prescribed ART medications, reported ART non-adherence in past 30 days, were able to hear on the telephone, passed a brief cognitive screener ([@R10]) and were willing to participate in a randomized controlled trial. About 1101 persons were assessed for eligibility. As many as 633 people were excluded from the pool (adherent to medications = 517, under age 50 = 48, not on HIV medications = 46, declined participation = 21, did not past cognitive screener = 1). This resulted in a final sample of 452 (see "Results" for details on surveyed sample).

Measures {#s5}
--------

### Demographic information {#s6}

Demographic information included self-reported age, race/ethnicity, educational level, gender, sexual orientation, relationship status, employment/disability status, substance use history, HIV diagnosis duration, CD4, and viral load.

### Chronic disease {#s7}

A modified 21-item chronic illness checklist was administered at baseline to identify persons with comorbid chronic conditions ([@R5]). This checklist has been modified for use in other projects targeting older adults ([@R4]; [@R40]). This measure includes HANA and non-HIV associated illnesses. We adapted this measure for use with older PLWH by including hepatitis and hemophilia in the list of chronic conditions. Chronic disease burden was defined by the number of chronic medical conditions, excluding HIV diagnosis and depression.

### Perceived stress scale {#s8}

The four-item Perceived Stress Scale (PSS; [@R15]) was used to evaluate global stress levels. The PSS yields a total perceived stress score, with higher scores indicating greater stress (range = 4--20).

### Quality of life {#s9}

The Short Form 36, Version 2 (SF-36) was used to evaluate functional status and HRQOL ([@R52]). The SF-36 is widely used and has been found to have acceptable psychometric properties across different illness and age populations ([@R36]). The SF-36 has been utilized in monitoring health outcomes in patients with a variety of illnesses including HIV ([@R43]; [@R44]) as well as a wide range of diseases and chronic conditions commonly reported by HIV-positive patients who are 50 years or older including heart disease, diabetes, chronic pain, ([@R1]; [@R14]) depression ([@R14]), and Hepatitis C ([@R53]). For the purposes of this study, we administered three of the eight SF-36 subscales: physical functioning, social functioning, and mental health. These subscales have been shown to be sensitive to change in prior trials ([@R6]; [@R14]; [@R20]) and tap into constructs we hypothesized were likely to change due to our intervention. We chose to use the general SF-36, rather than an HIV-specific, because it is a general measure of HRQOL that can be used across chronic diseases and because national norms are available ([@R44]). The SF-36 utilizes *t*-scores with higher *t*-scores indicating more positive functioning.

### Depression {#s10}

A modified eight-item version of the patient health questionnaire (PHQ) was used ([@R30]; [@R31]). The PHQ measures presence of DSM-IV major depression symptoms and can be scored as a continuous or categorical screening measure for depression. Prior work has shown the removal of the suicide ideation question to be acceptable in large samples of depressed individuals ([@R16]; [@R31]) (range = 0--24).

###### 

Demographics.

                                             n (%)
  ------------------------------------------ -----------
  *Age*                                      
  50--54 years old                           265 (59%)
  55--59 years old                           129 (29%)
  60+ years old                              58 (12%)
  *Sex*                                      
  Male                                       327 (72%)
  Female                                     125 (28%)
  *Ethnicity*                                
  African-American                           255 (56%)
  White/non-hispanic                         173 (38%)
  Hispanic/Latino                            30 (7%)
  Native American                            11 (2%)
  Asian                                      2 (0.04%)
  *Education*                                
  Less than high school                      81 (18%)
  High school                                142 (31%)
  Some college/college degree                186 (41%)
  Post graduate degree                       53 (10%)
  *Sexual orientation*                       
  Heterosexual                               248 (55%)
  Homosexual                                 157 (35%)
  Bisexual                                   39 (9%)
  Transgender or transsexual                 4 (1%)
  Refused/don\'t know                        4 (1%)
  *Relationship*                             
  Single                                     213 (47%)
  Married/partnered                          107 (24%)
  Divorced/separated                         95 (21%)
  Widowed                                    37 (8%)
  Ever injected drugs                        160 (35%)
  Undetectable viral load                    298 (66%)
  Ever been diagnosed with AIDS              242 (54%)
  *HIV duration*                             
  Less than 5 years                          32 (7%)
  5--9 years                                 60 (13%)
  10--14 years                               117 (26%)
  15--19 years                               120 (27%)
  20+ years                                  121 (27%)
  Self-reported depression in last 3 years   242 (64%)
  Most recent CD4, Mean (SD)                 514 (329)

Results {#s11}
=======

[Table 1](#T1){ref-type="table"} describes the demographics, rates of injection drug use, and viral load in the study population. The sample is primarily heterosexual African-American men. The mean age was 55.8 years (SD = 4.3, range 50--75) and approximately 82% of the sample attained at least a high school diploma.

[Figure 1](#F1){ref-type="fig"} presents the percentages of people reporting the number of chronic health conditions other than HIV (also excluding depression). The number of chronic conditions reported was high, the modal number of chronic illness in addition to HIV was 2 (mean = 3.8, SD = 2.6), with a reported range of 0--15 chronic conditions. The top chronic illnesses were high blood pressure (46%), chronic pain other than back pain and headache (45%), hepatitis (39%), and arthritis (35%), and chronic back pain (33%), asthma (32%), and diabetes (21%) ([Figure 2](#F2){ref-type="fig"}).

![Number of self-reported chronic conditions in addition to HIV, excluding depression.](caic25_451_f1){#F1}

![Type of self-reported chronic conditions.](caic25_451_f2){#F2}

Self-reported functioning as assessed by the SF-36 demonstrated relatively high functioning for the sample, with better social functioning (mean = 66.0, SD = 28.7), followed by mental health functioning (mean = 60.0, SD = 16.5), and physical functioning (mean = 58.2, SD = 26.3). Mean depression scores are considered in the mild range with a mean of 7.3 (SD = 5.7). Utilizing the scoring criteria for diagnostic screening, 14% (*n* = 63) of the sample reported symptoms consistent with Major Depression according to DSM-IV criteria. Perceived stress scores indicate a moderate level of reported stress for the sample (*M* = 9.7, SD = 3.4).

Physical, social, and mental health functioning, stress, and depression were all strongly associated with the number of chronic conditions ([Table 2](#T2){ref-type="table"}). Unadjusted and adjusted regression models were conducted. For the adjusted model, we used a least-squares regression analysis controlling for age group (under 55, 55--59, 60 +), gender, racial group (white vs. African-American vs. other), and education level (high school graduate or less vs. some college or higher) and self-reported most recent CD4. The SF-36 *t*-scores declined as the number of chronic conditions increased, decreasing by 4.8 points for physical functioning, 3.7 for social functioning, and 2.1 units for mental health functioning per additional chronic illness. Depression symptom severity increased as the number of chronic conditions increased by an estimated 0.9 units per additional condition. Perceived stress increased as the number of chronic conditions increased by an average of 0.4 units.

Discussion {#s12}
==========

Results from this study underscore the importance of examining the overall health of older individuals with HIV. Compared to the general population of person\'s 50 years and older in the US our sample had more chronic health conditions. For example in a US sample taken in 2005, 79.7% of person\'s 50+ had a chronic illness, while in our sample in addition to HIV 94% of our sample reported a chronic illness ([@R2]). Prior research has indicated that person\'s age 50 years and older with HIV are at greater risk of certain types of illnesses ([@R9]; [@R17]; [@R19]). In HIV-positive populations, a comorbid chronic illness is often reported in isolation from other conditions rather than examining the multiple chronic conditions that co-occur. In our sample of person\'s 50 years and older with HIV, 94% reported at least one additional illness, with an average of two additional chronic health problems, three conditions when depression was included. These results are similar to Karpiak and colleagues ([@R8]) findings (*M* = 3 conditions) in a large sample of HIV-positive persons aged 50 plus, living in New York City in which depression was also included in the chronic condition tally. [@R51] also reported that those HIV-positive over the age of 50 averaged four additional chronic conditions, significantly higher than their younger counterparts. However, our rates of chronic conditions are lower than what was demonstrated in a large sample of HIV-positive veterans which showed approximately half to two-thirds of those over the age of 50 had an additional physical health comorbidity ([@R22]). Our sample extends the literature by examining a community sample of persons in multiple cities across the US. Hypertension, chronic pain, hepatitis, arthritis, respiratory conditions, and diabetes were the most common chronic conditions reported by older adults participating in our study.

###### 

Relationship between quality of life variables and number of chronic conditions.

                                                                                 Unadjusted   Adjusted            
  ---------------------------------------------------------------- ------------- ------------ ---------- -------- ----------
  SF physical functioning[^a^](#T2FN1){ref-type="table-fn"}        58.2 (26.3)   − 5.01       \<0.0001   − 4.78   \<0.0001
  SF social functioning[^a^](#T2FN1){ref-type="table-fn"}          66.0 (28.7)   − 3.77       \<0.0001   − 3.71   \<0.0001
  SF mental health functioning[^a^](#T2FN1){ref-type="table-fn"}   60.0 (16.5)   − 2.25       \<0.0001   − 2.13   \<0.0001
  Depression[^b^](#T2FN2){ref-type="table-fn"}                     7.3 (5.7)     0.9          \<0.0001   0.89     \<0.0001
  Perceived stress[^c^](#T2FN3){ref-type="table-fn"}               9.6 (3.44)    0.39         \<0.0001   0.36     \<0.0001

Note: "Beta" gives the average change per additional chronic condition.

Range 0 (worst) to 100 (best).

Range 0 (no symptoms) to 24 (severe symptoms).

Range 4 (low) to 24 (high).

Adjusted for age group (under 55, 55--59, 60 +), gender, racial group (white vs. African-American vs. other), and education level (high school graduate or less vs. some college or more education) and self-reported last CD4 value using least-squares regression analysis.

For purposes of this study\'s analysis we focused on physical health problems, thus removing mental health problems such as depression. However, depression should not be overlooked as important clinical variable for this population. In our sample, we found 64% reporting an episode of depression in the last 3 years. When the PHQ-8 scores are examined for current depressive symptomatology, the sample overall reports a mild level of depression. However, 14% of the sample indicates clinically significant depression at time of assessment. This is considered a higher rate than one would expect in the general population, which has previously been reported by the CDC to be 4--7% in an adult population sample using the PHQ-9 ([@R41]) and a 50+ HIV-positive sample of veterans rates were 6--11%. Our finding reiterates prior findings ([@R42]) that unlike other illness populations, older adults with HIV do not have a decrease in depression with age but have an increase or ongoing maintenance of depressive symptoms with older age.

Despite relatively high rates of depression, overall QoL was moderately high for the sample. Also, mental health was not the major QoL variable that was influenced by the presence of additional chronic illnesses. When we looked at QoL variables, it was physical functioning that was most impacted by the addition of other chronic health problems, followed by social functioning and finally mental health functioning. Results demonstrated a moderate level of overall stress for the sample which significantly increased with addition of other chronic health problems.

Findings from the current study indicate that for persons 50 years and older with HIV, additional chronic health problems are the norm. This raises a challenge for patient-centered care with HIV-positive older adults. Historically, HIV care has often been portioned off by specialists, adept in HIV care and treating potential opportunistic infections. However, less attention was needed for other chronic health conditions often associated with age. As increasing numbers of HIV-positive people reach older age, healthcare must consider how it will address the needs of this population. Caring for older individuals with HIV must take into account the whole person, proceed with a more comprehensive consideration of health and be poised to address both the specific health concerns of HIV but also the high likelihood of other chronic health conditions. This challenge extends beyond HIV and other physical illnesses to mental health diagnoses as witnessed by higher rates of reported depressive symptoms.
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